Drug & Medication Database

Dosage form: POWDER. Active ingredients: SIPONIMOD (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION PROVENGE (sipuleucel-T) is an autologous cellular immunotherapy available as a suspension for intravenous infusion. PROVENGE consists of autologous peripheral blood mononuclear cells, including antigen presenting cells (APCs), that have been activated during a defined culture period with a recombinant human protein, PAP-GM-CSF, consisting of prostatic acid phosphatase (PAP), an antigen expressed in prostate cancer tissue, linked to granulocyte-macrophage colony-stimulating factor.

Brands: Provenge

11 DESCRIPTION FYARRO (sirolimus protein-bound particles for injectable suspension) (albumin-bound) is sirolimus formulated as albumin-bound nanoparticles. The active ingredient in FYARRO is sirolimus bound to albumin which exists in the nanoparticles in a non-crystalline, amorphous state. Sirolimus is a mechanistic target of rapamycin kinase (mTOR) inhibitor. Sirolimus is a macrocyclic lactone produced by Streptomyces hygroscopicus .

Brands: Fyarro

Dosage form: POWDER. Active ingredients: SIROLIMUS (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: SIROLIMUS (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: INJECTION. Route: CUTANEOUS, INTRADERMAL, SUBCUTANEOUS. Active ingredients: AGAVE SISALANA FIBER (.1 g/mL). Category: BLA.

Brands: Sisal

Dosage form: POWDER. Active ingredients: SISOMICIN (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION JANUVIA Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme. Sitagliptin phosphate monohydrate is described chemically as 7-[(3 R )-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3- a ]pyrazine phosphate (1:1) monohydrate. The empirical formula is C 16 H 15 F 6 N 5 O•H 3 PO 4 •H 2 O and the molecular weight is 523.32.

Brands: Januvia

Brands: Zituvimet Xr

Dosage form: POWDER. Active ingredients: SITAGLIPTIN PHOSPHATE ANHYDROUS (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: SITAGLIPTIN (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: SITAGLIPTIN PHOSPHATE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: SITAGLIPTIN HYDROCHLORIDE (25 kg/25kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: SITAGLIPTIN HYDROCHLORIDE (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION BRYNOVIN (sitagliptin) oral solution contains sitagliptin hydrochloride (HCl), an orally-active inhibitor of the DPP-4 enzyme. Sitagliptin HCl is described chemically as ((3R)-3-Amino-1-(3-(trifluoromethy1)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-y1)-4-(2,4,5-trifluorophenyl)butan-l-one HCl monohydrate. The empirical formula is C 16 H 15 F 6 N 5 O•HCl.H 2 O and the molecular weight is 461.79.

Brands: Brynovin

Dosage form: POULTICE. Active ingredients: SITAGLIPTIN (100 kg/100kg). Category: BULK INGREDIENT.

Dosage form: TABLET. Active ingredients: SITAGLIPTIN PHOSPHATE (50 mg/1). Category: DRUG FOR FURTHER PROCESSING.

Dosage form: TABLET, FILM COATED, EXTENDED RELEASE. Active ingredients: METFORMIN HYDROCHLORIDE (1000 mg/1); SITAGLIPTIN PHOSPHATE (50 mg/1). Category: DRUG FOR FURTHER PROCESSING.

Dosage form: POWDER. Active ingredients: SITAGLIPTIN PHOSPHATE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: SITAGLIPTIN PHOSPHATE ANHYDROUS (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: SITAGLIPTIN PHOSPHATE ANHYDROUS (50 kg/50kg). Category: BULK INGREDIENT.

Manufactured by MSN LABORATORIES PRIVATE LTD. Dosage form: TABLET. Active ingredients: SITAGLIPTIN PHOSPHATE ANHYDROUS, METFORMIN HYDROCHLORIDE (100MG). Application: ANDA217395.

Dosage form: POWDER. Active ingredients: SITAGLIPTIN PHOSPHATE (1 kg/kg). Category: BULK INGREDIENT.

Manufactured by SINOTHERAPEUTICS INC. Dosage form: TABLET, EXTENDED RELEASE. Active ingredients: SITAGLIPTIN, METFORMIN HYDROCHLORIDE (500MG). Application: ANDA212869.

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Sixth Chakra (third Eye) 7306

Uses: See symptoms on front panel. Relieves headache associated with constipation *

Brands: Lac Defloratum

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Skin Balance Liquescence 3027

Skin Protectant

Brands: Curology Barrier Balm

Purpose Sunscreen

Brands: Sunscreen

Wart Remover

Brands: Skin Care Removal